TY - JOUR
T1 - Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
T2 - Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group
AU - Spaide, Richard F.
AU - Jaffe, Glenn J.
AU - Sarraf, David
AU - Freund, K. Bailey
AU - Sadda, Srinivas R.
AU - Staurenghi, Giovanni
AU - Waheed, Nadia K.
AU - Chakravarthy, Usha
AU - Rosenfeld, Philip J.
AU - Holz, Frank G.
AU - Souied, Eric H.
AU - Cohen, Salomon Y.
AU - Querques, Giuseppe
AU - Ohno-Matsui, Kyoko
AU - Boyer, David
AU - Gaudric, Alain
AU - Blodi, Barbara
AU - Baumal, Caroline R.
AU - Li, Xiaoxin
AU - Coscas, Gabriel J.
AU - Brucker, Alexander
AU - Singerman, Lawrence
AU - Luthert, Phil
AU - Schmitz-Valckenberg, Steffen
AU - Schmidt-Erfurth, Ursula
AU - Grossniklaus, Hans E.
AU - Wilson, David J.
AU - Guymer, Robyn
AU - Yannuzzi, Lawrence A.
AU - Chew, Emily Y.
AU - Csaky, Karl
AU - Monés, Jordi M.
AU - Pauleikhoff, Daniel
AU - Tadayoni, Ramin
AU - Fujimoto, James
N1 - Publisher Copyright:
© 2019 American Academy of Ophthalmology
PY - 2020/5
Y1 - 2020/5
N2 - Purpose: To establish a process to evaluate and standardize a state-of-the-art nomenclature for reporting neovascular age-related macular degeneration (AMD) data. Design: Consensus meeting. Participants: An international panel of retina specialists, imaging and image reading center experts, and ocular pathologists. Methods: During several meetings organized under the auspices of the Macula Society, an international study group discussed and codified a set nomenclature framework for classifying the subtypes of neovascular AMD and associated lesion components. Main Outcome Measures: A consensus classification of neovascular AMD. Results: The study group created a standardized working definition of AMD. The components of neovascular AMD were defined and subclassified. Disease consequences of macular neovascularization were delineated. Conclusions: The framework of a consensus nomenclature system, a definition of AMD, and a delineation of the subtypes of neovascular AMD were developed. Establishing a uniform set of definitions will facilitate comparison of diverse patient groups and different studies. The framework presented is modified and updated readily, processes that are anticipated to occur on a periodic basis. The study group suggests that the consensus standards outlined in this article be used in future reported studies of neovascular AMD and clinical practice.
AB - Purpose: To establish a process to evaluate and standardize a state-of-the-art nomenclature for reporting neovascular age-related macular degeneration (AMD) data. Design: Consensus meeting. Participants: An international panel of retina specialists, imaging and image reading center experts, and ocular pathologists. Methods: During several meetings organized under the auspices of the Macula Society, an international study group discussed and codified a set nomenclature framework for classifying the subtypes of neovascular AMD and associated lesion components. Main Outcome Measures: A consensus classification of neovascular AMD. Results: The study group created a standardized working definition of AMD. The components of neovascular AMD were defined and subclassified. Disease consequences of macular neovascularization were delineated. Conclusions: The framework of a consensus nomenclature system, a definition of AMD, and a delineation of the subtypes of neovascular AMD were developed. Establishing a uniform set of definitions will facilitate comparison of diverse patient groups and different studies. The framework presented is modified and updated readily, processes that are anticipated to occur on a periodic basis. The study group suggests that the consensus standards outlined in this article be used in future reported studies of neovascular AMD and clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=85076825569&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076825569&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2019.11.004
DO - 10.1016/j.ophtha.2019.11.004
M3 - Article
C2 - 31864668
AN - SCOPUS:85076825569
SN - 0161-6420
VL - 127
SP - 616
EP - 636
JO - Ophthalmology
JF - Ophthalmology
IS - 5
ER -